An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...
Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of ...
New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Networkfound that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...
A large analysis of two major clinical trials has found that the spread of prostate cancer can be detected on imaging scans even when biomarkers remain stable in patients treated with androgen ...
Clinical validation of a comprehensive genomic profiling–based approach for homologous recombination deficiency assessment. Early circulating tumor DNA dynamics as a prognostic and predictive ...
Study findings further strengthen pivotal role of PSMA PET in the management of men with recurrence of prostate cancer after ...
This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers Symposium. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results